CYCLERION THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
CYCLERION THERAPEUTICS, INC. (CYCN) reported Increase (Decrease) in Accounts Payable of $2.89 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2019-05-13
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2019-03-31 was $2.89M, a 112.19% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2018-03-31 was $1.36M.
| Period end | Increase (Decrease) in Accounts Payable 3 month |
|---|---|
| 2019-03-31 | $2.89M 10-Q · filed 2019-05-13 |
| 2018-03-31 | $1.36M 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |